Furthermore, just like tirzepatide is not truly a GLP-2 treatment, retatrutide is not truly a GLP-3 treatment
This medication has a 94% similarity to human GLP-1, making it highly effective at binding to and activating GLP-1 receptors [3]
North Carolina has a large and geographically diverse population, from the dense Research Triangle and Charlotte metro to the rural mountain counties of the west and the coastal plain in the east
However, symptoms should greatly improve or be alleviated with the continued use of supplements
It is widely available as an over-the-counter dietary supplement, with the global market valued at $58.1 million in 2023, projected to grow to $97.5 million by 2033 [5]
This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 10 mg vial format